V6L-11467-39597
3 vaccinations
2 coded responses
14 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 440 / OH
- Registered
- 2021-12-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-13
Dose 1 — Pfizer-BioNTech
-
2021-06-06
Dose 2 — Pfizer-BioNTech
-
2021-12-11
Registered in v-safe
-
2021-12-11
Dose 3 — Pfizer-BioNTech
- 2021-12-11
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-13
- 2021-12-15
- 2021-12-16
- 2021-12-18
- 2021-12-28
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-01-22
-
2022-03-14
Survey response — 3 months, dose 3MedDRA: Hypertension, Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Hypertension but I'm in my third trimester · Healthcare visit (other): Ob/gynMedDRA releases: 2024-11 · check-in free text available
-
2022-03-14
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-16
- 2022-06-11
-
2022-12-13
Survey response — 12 months, dose 3MedDRA: Chest pain, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Non specific chest pain. Maybe costochondritis. · Healthcare visit (other): PcpMedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-12-14
- 2022-12-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-13 | Pfizer-BioNTech | No |
| 2 | 2021-06-06 | Pfizer-BioNTech | No |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-14 | Unsuccessful | |
| 2022-12-13 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release